Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial

ACTIVE NOT RECRUITING

Identifier: CI-TRIAL-00122356
Entity page: /trial/NCT04513717 ↗
Edges: 13

Neighbours: 2 cancers10 drugs
Drawn: 12 of 12 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial condition of …CONDITION_OFderived3 of 3
← condition of	Malignant Prostate Neoplasm registry condition “Stage III Prostate Cancer AJCC v8” mapped CURATED_BROADER	—	—	Malignant Prostate Neoplasm	1	Observed	clinicaltrials	graph →
← condition of	Malignant Prostate Neoplasm registry condition “Stage IVA Prostate Cancer AJCC v8” mapped CURATED_BROADER

Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial intervention of …INTERVENTION_OFderived10 of 10
← intervention of	Apalutamidesmall molecule registry intervention “Apalutamide” (DRUG) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →
← intervention of	Bicalutamidesmall molecule registry intervention “Bicalutamide” (DRUG) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →
← intervention of	Buserelinother registry intervention “Buserelin” (DRUG) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →
← intervention of	Degarelixother registry intervention “Degarelix” (DRUG) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →
← intervention of	Flutamidesmall molecule registry intervention “Flutamide” (DRUG) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →
← intervention of	Goserelinother registry intervention “Goserelin” (DRUG) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →
← intervention of	Histrelinother registry intervention “Histrelin” (DRUG) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →
← intervention of	Leuprolideother registry intervention “Leuprolide” (DRUG) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →
← intervention of	Relugolixsmall molecule registry intervention “Relugolix” (DRUG) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →
← intervention of	Triptorelinother registry intervention “Triptorelin” (DRUG) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →

Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial intervention of …INTERVENTION_OFderived10 of 10

← intervention of

Apalutamidesmall molecule

registry intervention “Apalutamide” (DRUG) mapped ALIAS

—

not mapped

Observed

clinicaltrials

graph →

← intervention of

Bicalutamidesmall molecule

registry intervention “Bicalutamide” (DRUG) mapped ALIAS

—